Publications

  1. Arnold SV, Hahn RT, Thourani VH, Makkar R, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O'Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran N, Garcia S, Stewart-Dehner T, Grayburn PA, Sannino A, Snyder C, Zhang Y, Mack MJ, Leon MB, Lurz P, Kodali S, Cohen DJ, TRISCEND II Pivotal Trial Investigators. Quality of Life After Transcatheter Tricuspid Valve Replacement: 1-Year Results From TRISCEND II Pivotal Trial. J Am Coll Cardiol. 2025 Jan 28; 85 (3):206-216 Epub 2024 Oct 30
    View PubMed
  2. Phillips M, Hahn RT, Makkar R, Thourani VH, Makar M, Sharma RP, Haeffele C, Davidson CJ, Narang A, O'Neill B, Lee J, Yadav P, Zahr F, Chadderdon S, Eleid M, Pislaru S, Smith R, Szerlip M, Whisenant B, Sekaran NK, Garcia S, Stewart-Dehner T, Thiele H, Kipperman R, Koulogiannis K, Lim DS, Fowler D, Kapadia S, Harb SC, Grayburn PA, Sannino A, Mack MJ, Leon MB, Lurz P, Kodali SK, TRISCEND II Trial Investigators. Transcatheter Valve Replacement in Severe Tricuspid Regurgitation. N Engl J Med. 2025 Jan 9; 392 (2):115-126 Epub 2024 Oct 30
    View PubMed
  3. Parney IF, Anderson SK, Gustafson MP, Steinmetz S, Peterson TE, Kroneman TN, Raghunathan A, O'Neill BP, Buckner JC, Solseth M, Dietz AB. Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac089. Epub 2022 Jun 24.
    View PubMed
  4. Breen WG, Anderson SK, Carrero XW, Brown PD, Ballman KV, O'Neill BP, Curran WJ, Abrams RA, Laack NN, Levitt R, Galanis E, Buckner JC, Shaw EG. Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma. Neuro Oncol. 2020 Jun 9; 22 (6):830-837
    View PubMed
  5. Vaubel RA, Tian S, Remonde D, Schroeder MA, Mladek AC, Kitange GJ, Caron A, Kollmeyer TM, Grove R, Peng S, Carlson BL, Ma DJ, Sarkar G, Evers L, Decker PA, Yan H, Dhruv HD, Berens ME, Wang Q, Marin BM, Klee EW, Califano A, LaChance DH, Eckel-Passow JE, Verhaak RG, Sulman EP, Burns TC, Meyer FB, O'Neill BP, Tran NL, Giannini C, Jenkins RB, Parney IF, Sarkaria JN. Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma. Clin Cancer Res. 2020 Mar 1; 26 (5):1094-1104 Epub 2019 Dec 18
    View PubMed
  6. Tun HW, Johnston PB, DeAngelis LM, Atherton PJ, Pederson LD, Koenig PA, Reeder CB, Omuro AMP, Schiff D, O'Neill B, Pulido J, Jaeckle KA, Grommes C, Witzig TE. Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma. Blood. 2018 Nov 22; 132 (21):2240-2248 Epub 2018 Sept 27
    View PubMed
  7. Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Monnat RJ Jr, Xiao Y, Wang C, Cancer Genome Atlas Research Network. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 Apr 3; 23 (1):239-254.e6
    View PubMed
  8. Bekaii-Saab T, Goldstein D, Li CP, Okusaka T, O'Neil B, Reni M, Tabernero J, Qin S, Van Cutsem E, Borodyansky L, Li CJ, other CanStem111P Investigators. CanStem111P trial: A phase III study of napabucasin plus nab-paclitaxel (nab-PTX) with gemcitabine (gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC). Ann Oncol. 2017 Jun; 28 Suppl 3:iii136
    View PubMed
  9. Hu LS, Ning S, Eschbacher JM, Baxter LC, Gaw N, Ranjbar S, Plasencia J, Dueck AC, Peng S, Smith KA, Nakaji P, Karis JP, Quarles CC, Wu T, Loftus JC, Jenkins RB, Sicotte H, Kollmeyer TM, O'Neill BP, Elmquist W, Hoxworth JM, Frakes D, Sarkaria J, Swanson KR, Tran NL, Li J, Mitchell JR. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. Neuro Oncol. 2017 Jan; 19 (1):128-137 Epub 2016 Aug 08
    View PubMed
  10. Carreras E, Salomao DR, Nadal J, Amin SR, Raja H, Grube TJ, Geraets RL, Johnston PB, O'Neill BP, Pulido JS. Macular edema is a rare finding in untreated vitreoretinal lymphoma: small case series and review of the literature. Int J Retina Vitreous. 2017; 3:15 Epub 2017 Apr 24
    View PubMed
  11. Nguyen QD, Perry A, Graffeo CS, Nesvick CL, Raghunathan A, Jentoft ME, O'Neill BP, Morris PP, Morris JM, Van Gompel JJ. Gliosarcoma with Primary Skull Base Invasion. Case Rep Radiol. 2016; 2016:1762195. Epub 2016 Dec 08.
    View PubMed
  12. Brown PD, Anderson SK, Carrero XW, O'Neill BP, Giannini C, Galanis E, Shah SA, Abrams RA, Curran WJ Jr, Buckner JC, Shaw EG. Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance). Neurooncol Pract. 2015 Dec; 2 (4):199-204 Epub 2015 Aug 06
    View PubMed
  13. Braggio E, Van Wier S, Ojha J, McPhail E, Asmann YW, Egan J, da Silva JA, Schiff D, Lopes MB, Decker PA, Valdez R, Tibes R, Eckloff B, Witzig TE, Stewart AK, Fonseca R, O'Neill BP. Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas. Clin Cancer Res. 2015 Sep 1; 21 (17):3986-94 Epub 2015 May 19
    View PubMed
  14. Kumar R, Laack N, Pollock BE, Link M, O'Neill BP, Parney IF. Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma. World Neurosurg. 2015 Aug; 84: (2)390-7.
    View PubMed
  15. Kasenda B, Ferreri AJ, Marturano E, Forst D, Bromberg J, Ghesquieres H, Ferlay C, Blay JY, Hoang-Xuan K, Pulczynski EJ, Fossa A, Okoshi Y, Chiba S, Fritsch K, Omuro A, O'Neill BP, Bairey O, Schandelmaier S, Gloy V, Bhatnagar N, Haug S, Rahner S, Batchelor TT, Illerhaus G, Briel M. First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis. Ann Oncol. 2015 Jul; 26 (7):1305-13 Epub 2015 Feb 20
    View PubMed
  16. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O'Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med. 2015 Jun 25; 372 (26):2499-508 Epub 2015 June 10
    View PubMed
  17. Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, Akbani R, Huse JT, Ciriello G, Poisson LM, Barnholtz-Sloan JS, Berger MS, Brennan C, Colen RR, Colman H, Flanders AE, Giannini C, Grifford M, Iavarone A, Jain R, Joseph I, Kim J, Kasaian K, Mikkelsen T, Murray BA, O'Neill BP, Pachter L, Parsons DW, Sougnez C, Sulman EP, Vandenberg SR, Van Meir EG, von Deimling A, Zhang H, Crain D, Lau K, Mallery D, Morris S, Paulauskis J, Penny R, Shelton T, Sherman M, Yena P, Black A, Bowen J, Dicostanzo K, Gastier-Foster J, Leraas KM, Lichtenberg TM, Pierson CR, Ramirez NC, Taylor C, Weaver S, Wise L, Zmuda E, Davidsen T, Demchok JA, Eley G, Ferguson ML, Hutter CM, Mills Shaw KR, Ozenberger BA, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Ayala B, Baboud J, Chudamani S, Jensen MA, Liu J, Pihl T, Raman R, Wan Y, Wu Y, Ally A, Auman JT, Balasundaram M, Balu S, Baylin SB, Beroukhim R, Bootwalla MS, Bowlby R, Bristow CA, Brooks D, Butterfield Y, Carlsen R, Carter S, Chin L, Chu A, Chuah E, Cibulskis K, Clarke A, Coetzee SG, Dhalla N, Fennell T, Fisher S, Gabriel S, Getz G, Gibbs R, Guin R, Hadjipanayis A, Hayes DN, Hinoue T, Hoadley K, Holt RA, Hoyle AP, Jefferys SR, Jones S, Jones CD, Kucherlapati R, Lai PH, Lander E, Lee S, Lichtenstein L, Ma Y, Maglinte DT, Mahadeshwar HS, Marra MA, Mayo M, Meng S, Meyerson ML, Mieczkowski PA, Moore RA, Mose LE, Mungall AJ, Pantazi A, Parfenov M, Park PJ, Parker JS, Perou CM, Protopopov A, Ren X, Roach J, Sabedot TS, Schein J, Schumacher SE, Seidman JG, Seth S, Shen H, Simons JV, Sipahimalani P, Soloway MG, Song X, Sun H, Tabak B, Tam A, Tan D, Tang J, Thiessen N, Triche T Jr, Van Den Berg DJ, Veluvolu U, Waring S, Weisenberger DJ, Wilkerson MD, Wong T, Wu J, Xi L, Xu AW, Yang L, Zack TI, Zhang J, Aksoy BA, Arachchi H, Benz C, Bernard B, Carlin D, Cho J, DiCara D, Frazer S, Fuller GN, Gao J, Gehlenborg N, Haussler D, Heiman DI, Iype L, Jacobsen A, Ju Z, Katzman S, Kim H, Knijnenburg T, Kreisberg RB, Lawrence MS, Lee W, Leinonen K, Lin P, Ling S, Liu W, Liu Y, Liu Y, Lu Y, Mills G, Ng S, Noble MS, Paull E, Rao A, Reynolds S, Saksena G, Sanborn Z, Sander C, Schultz N, Senbabaoglu Y, Shen R, Shmulevich I, Sinha R, Stuart J, Sumer SO, Sun Y, Tasman N, Taylor BS, Voet D, Weinhold N, Weinstein JN, Yang D, Yoshihara K, Zheng S, Zhang W, Zou L, Abel T, Sadeghi S, Cohen ML, Eschbacher J, Hattab EM, Raghunathan A, Schniederjan MJ, Aziz D, Barnett G, Barrett W, Bigner DD, Boice L, Brewer C, Calatozzolo C, Campos B, Carlotti CG Jr, Chan TA, Cuppini L, Curley E, Cuzzubbo S, Devine K, DiMeco F, Duell R, Elder JB, Fehrenbach A, et al, Cancer Genome Atlas Research Network. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372 (26):2481-98 Epub 2015 June 10
    View PubMed
  18. Alexander BM, Galanis E, Yung WK, Ballman KV, Boyett JM, Cloughesy TF, Degroot JF, Huse JT, Mann B, Mason W, Mellinghoff IK, Mikkelsen T, Mischel PS, O'Neill BP, Prados MD, Sarkaria JN, Tawab-Amiri A, Trippa L, Ye X, Ligon KL, Berry DA, Wen PY. Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group. Neuro Oncol. 2015 Feb; 17 (2):180-8 Epub 2014 Aug 26
    View PubMed
  19. Woehrer A, Lau CC, Prayer D, Bauchet L, Rosenfeld M, Capper D, Fisher PG, Kool M, Muller M, Kros JM, Kruchko C, Wiemels J, Wrensch M, Danysh HE, Zouaoui S, Heck JE, Johnson KJ, Qi X, O'Neill BP, Afzal S, Scheurer ME, Bainbridge MN, Nousome D, Bahassi M, Hainfellner JA, Barnholtz-Sloan JS, Brain Tumor Epidemiology Consortium. Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014. Clin Neuropathol. 2015 Jan-Feb; 34 (1):40-6
    View PubMed
  20. Hu LS, Ning S, Eschbacher JM, Gaw N, Dueck AC, Smith KA, Nakaji P, Plasencia J, Ranjbar S, Price SJ, Tran N, Loftus J, Jenkins R, O'Neill BP, Elmquist W, Baxter LC, Gao F, Frakes D, Karis JP, Zwart C, Swanson KR, Sarkaria J, Wu T, Mitchell JR, Li J. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma. PLoS One. 2015; 10 (11):e0141506 Epub 2015 Nov 24
    View PubMed
  21. Wang J, Pulido JS, O'Neill BP, Johnston PB. Second malignancies in patients with primary central nervous system lymphoma. Neuro Oncol. 2015 Jan; 17 (1):129-35 Epub 2014 June 19
    View PubMed
  22. Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM, Kollmeyer T, Kosel ML, Molinaro AM, McCoy LS, Bracci PM, Cabriga BS, Pekmezci M, Zheng S, Wiemels JL, Pico AR, Tihan T, Berger MS, Chang SM, Prados MD, Lachance DH, O'Neill BP, Sicotte H, Eckel-Passow JE, van der Harst P, Wiencke JK, Samani NJ, Jenkins RB, Wrensch MR, ENGAGE Consortium Telomere Group. Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet. 2014 Jul; 46 (7):731-5 Epub 2014 June 08
    View PubMed
  23. Patrick O'Neill B, Braggio E, O'Neill BP, Van Wier S, Ojha J, McPhail E, Asmann Y, Egan J, Ayres da Silva J, Schiff D, Lopes MB, Valdez R, Tibes R, Eckloff B, Stewart AK, Fonseca R. Genome-wide analysis uncovers recurrent alterations in primary central nervous system lymphomas (pcnsl). Neuro Oncol. 2014 Jul; 16 Suppl 3:iii43.
    View PubMed
  24. Guan X, Vengoechea J, Zheng S, Sloan AE, Chen Y, Brat DJ, O'Neill BP, de Groot J, Yust-Katz S, Yung WK, Cohen ML, Aldape KD, Rosenfeld S, Verhaak RG, Barnholtz-Sloan JS. Molecular subtypes of glioblastoma are relevant to lower grade glioma. PLoS One. 2014; 9 (3):e91216 Epub 2014 Mar 10
    View PubMed
  25. Wang E, Zhang C, Polavaram N, Liu F, Wu G, Schroeder MA, Lau JS, Mukhopadhyay D, Jiang SW, O'Neill BP, Datta K, Li J. The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme. PLoS One. 2014; 9(1):e86102. Epub 2014 Jan 23.
    View PubMed
  26. O'Neill BP, Decker PA, Tieu C, Cerhan JR. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle-aged men and differs from time trends in systemic diffuse large B-cell non-Hodgkin's lymphoma. Am J Hematol. 2013 Dec; 88 (12):997-1000 Epub 2013 Sept 12
    View PubMed
  27. Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, Deangelis L, Baehring J, Nishikawa R, Pinto F, Chamberlain M, Hoang-Xuan K, Gonzalez-Aguilar A, Batchelor T, Blay JY, Korfel A, Betensky RA, Lopes MB, Schiff D. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013 Nov 5; 81 (19):1690-6 Epub 2013 Oct 09
    View PubMed
  28. Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM. [(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc. 2013 Nov; 88 (11):1204-12
    View PubMed
  29. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O'Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, TCGA Research Network. The somatic genomic landscape of glioblastoma. Cell. 2013 Oct 10; 155(2):462-77.
    View PubMed
  30. Rice T, Zheng S, Decker PA, Walsh KM, Bracci P, Xiao Y, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, Chang SM, Berger MS, Caron A, Fink S, Kollmeyer T, Rynearson A, Voss J, Kosel ML, Fridley BL, Lachance DH, Eckel-Passow JE, Sicotte H, O'Neill BP, Giannini C, Wiencke JK, Jenkins RB, Wrensch MR. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro Oncol. 2013 May; 15(5):535-41. Epub 2013 Jan 29.
    View PubMed
  31. Drucker KL, Paulsen AR, Giannini C, Decker PA, Blaber SI, Blaber M, Uhm JH, O'Neill BP, Jenkins RB, Scarisbrick IA. Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma. Neuro Oncol. 2013 Mar; 15 (3):305-18 Epub 2013 Jan 10
    View PubMed
  32. Johnson DR, O'Neill BP, Decker PA, Kosel ML, Lanzino G, Hammack JE. Mortality and discharge to home after closed brain biopsy: analysis of 3523 cases from the State of California, 2003-2009. World Neurosurg. 2013 Jan; 79: (1)110-5.
    View PubMed
  33. Raja H, Snyder MR, Johnston PB, O'Neill BP, Caraballo JN, Balsanek JG, Peters BE, Decker PA, Pulido JS. Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma. PLoS One. 2013; 8 (6):e65627 Epub 2013 June 04
    View PubMed
  34. Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM, Kosel ML, Zheng S, Walsh KM, Rice T, Bracci P, McCoy LS, Smirnov I, Patoka JS, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, Chang SM, Berger MS, Caron AA, Fink SR, Halder C, Rynearson AL, Fridley BL, Buckner JC, O'Neill BP, Giannini C, Lachance DH, Wiencke JK, Eckel-Passow JE, Wrensch MR. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet. 2012 Oct; 44 (10):1122-5 Epub 2012 Aug 26
    View PubMed
  35. Johnson DR, Sawyer AM, Meyers CA, O'Neill BP, Wefel JS. Early measures of cognitive function predict survival in patients with newly diagnosed glioblastoma. Neuro Oncol. 2012 Jun; 14 (6):808-16 Epub 2012 Apr 16
    View PubMed
  36. Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR. SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res. 2012 Jun 01; 18(11):3154-62. Epub 2012 Apr 03.
    View PubMed
  37. Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM. Secondary intramedullary spinal cord non-Hodgkin's lymphoma. J Neurooncol. 2012 May; 107 (3):575-80 Epub 2011 Dec 22
    View PubMed
  38. Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012 Apr; 107 (2):359-64 Epub 2011 Nov 02
    View PubMed
  39. Laack NN, O'Neill BP, Ballman KV, O'Fallon JR, Carrero XW, Kurtin PJ, Scheithauer BW, Brown PD, Habermann TM, Colgan JP, Gilbert MR, Hawkins RB, Morton RF, Windschitl HE, Fitch TR, Pajon ER Jr, North Central Cancer Treatment Group and Mayo Clinic. CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81 (2):476-82 Epub 2010 Aug 26
    View PubMed
  40. Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol. 2011 Sep 1; 174 (5):574-81 Epub 2011 July 08
    View PubMed
  41. Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology. 2011 Aug 23; 77 (8):784-91 Epub 2011 Aug 10
    View PubMed
  42. Braggio E, McPhail ER, Macon W, Lopes MB, Schiff D, Law M, Fink S, Sprau D, Giannini C, Dogan A, Fonseca R, O'Neill BP. Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens. Clin Cancer Res. 2011 Jul 1; 17 (13):4245-53 Epub 2011 May 11
    View PubMed
  43. Abla O, Weitzman S, Blay JY, O'Neill BP, Abrey LE, Neuwelt E, Doolittle ND, Baehring J, Pradhan K, Martin SE, Guerrera M, Shah S, Ghesquieres H, Silver M, Betensky RA, Batchelor T. Primary CNS lymphoma in children and adolescents: a descriptive analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG). Clin Cancer Res. 2011 Jan 15; 17(2):346-52. Epub 2011 Jan 11.
    View PubMed
  44. Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, O'Neill BP, Lachance DH, Yang P, Wiemels J, Wiencke JK. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet. 2011 Jan; 204 (1):13-8
    View PubMed
  45. Braggio E, O'Neill BP, Macon W, Lopes MB, Schiff D, Fonseca R. Characterization of the Copy Number Changes In Primary CNS Lymphomas (PCNSL) by High Resolution Array Based Comparative Genomic Hybridization. Blood. 2010 Nov 19; 116(21):438-9.
  46. Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol. 2010 Jul; 12 (7):631-44 Epub 2010 Feb 23
    View PubMed
  47. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, Kollmeyer TM, Kosel ML, LaChance DH, McCoy L, O'Neill BP, Patoka J, Pico AR, Prados M, Quesenberry C, Rice T, Rynearson AL, Smirnov I, Tihan T, Wiemels J, Yang P, Wiencke JK. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009 Aug; 41(8):905-8. Epub 2009 Jul 05.
    View PubMed
  48. Schomas DA, Laack NN, Rao RD, Meyer FB, Shaw EG, O'Neill BP, Giannini C, Brown PD. Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol. 2009 Aug; 11 (4):437-45 Epub 2008 Nov 18
    View PubMed
  49. Pulido JS, Vierkant RA, Olson JE, Abrey L, Schiff D, O'Neill BP. Racial differences in primary central nervous system lymphoma incidence and survival rates. Neuro Oncol. 2009 Jun; 11 (3):318-22 Epub 2009 Mar 09
    View PubMed
  50. Cady FM, O'Neill BP, Law ME, Decker PA, Kurtz DM, Giannini C, Porter AB, Kurtin PJ, Johnston PB, Dogan A, Remstein ED. Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol. 2008 Oct 10; 26 (29):4814-9 Epub 2008 July 21
    View PubMed
  51. Porter AB, Giannini C, Kaufmann T, Lucchinetti CF, Wu W, Decker PA, Atkinson JL, O'Neill BP. Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol. 2008 May; 63 (5):662-7
    View PubMed
  52. Tun HW, Personett D, Baskerville KA, Menke DM, Jaeckle KA, Kreinest P, Edenfield B, Zubair AC, O'Neill BP, Lai WR, Park PJ, McKinney M. Pathway analysis of primary central nervous system lymphoma. Blood. 2008 Mar 15; 111 (6):3200-10 Epub 2008 Jan 09
    View PubMed
  53. Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, Giannini C. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol. 2008 Mar; 67 (3):240-9
    View PubMed
  54. Rodriguez FJ, Thibodeau SN, Jenkins RB, Schowalter KV, Caron BL, O'neill BP, James CD, Passe S, Slezak J, Giannini C. MGMT immunohistochemical expression and promoter methylation in human glioblastoma. Appl Immunohistochem Mol Morphol. 2008 Jan; 16 (1):59-65
    View PubMed
  55. Kitzmann AS, Pulido JS, Mohney BG, Baratz KH, Grube T, Marler RJ, Donaldson MJ, O'Neill BP, Johnston PB, Johnson KM, Dixon LE, Salomao DR, Cameron JD. Intraocular use of rituximab. Eye (Lond). 2007 Dec; 21 (12):1524-7 Epub 2007 Apr 20
    View PubMed
  56. Karantanis D, O'eill BP, O'Neill BP, Subramaniam RM, Witte RJ, Mullan BP, Nathan MA, Lowe VJ, Peller PJ, Wiseman GA. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nucl Med Commun. 2007 Nov; 28: (11)834-41.
    View PubMed
  57. Buckner JC, Brown PD, O'Neill BP, Meyer FB, Wetmore CJ, Uhm JH. Central nervous system tumors. Mayo Clin Proc. 2007 Oct; 82 (10):1271-86
    View PubMed
  58. O'Neill BP, Vernino S, Dogan A, Giannini C. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro Oncol. 2007 Jul; 9 (3):364-9 Epub 2007 May 23
    View PubMed
  59. Rodriguez FJ, Eberhart C, O'Neill BP, Slezak J, Burger PC, Goldthwaite P, Wu W, Giannini C. Histopathologic grading of adult medulloblastomas. Cancer. 2007 Jun 15; 109 (12):2557-65
    View PubMed
  60. Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA, O'Neill BP, Fox E, MacDonald T, Beck H, Packer RJ. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol. 2007 May; 36 (5):293-300
    View PubMed
  61. Karantanis D, O'Neill BP, Subramaniam RM, Peller PJ, Witte RJ, Mullan BP, Wiseman GA. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Clin Nucl Med. 2007 Apr; 32(4):271-4.
    View PubMed
  62. Doolittle ND, Peereboom DM, Christoforidis GA, Hall WA, Palmieri D, Brock PR, Campbell KC, Dickey DT, Muldoon LL, O'Neill BP, Peterson DR, Pollock B, Soussain C, Smith Q, Tyson RM, Neuwelt EA. Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting. J Neurooncol. 2007 Jan; 81(1):81-91. Epub 2006 Jul 21.
    View PubMed
  63. Babovic-Vuksanovic D, Ballman K, Michels V, McGrann P, Lindor N, King B, Camp J, Micic V, Babovic N, Carrero X, Spinner R, O'Neill B. Phase II trial of pirfenidone in adults with neurofibromatosis type 1. Neurology. 2006 Nov 28; 67(10):1860-2. Epub 2006 Oct 11.
    View PubMed
  64. Gunduz K, Pulido JS, McCannel CA, O'Neill BP. Ocular manifestations and treatment of central nervous system lymphomas. Neurosurg Focus. 2006 Nov 15; 21 (5):E9
    View PubMed
  65. Laack NN, Ballman KV, Brown PB, O'Neill BP, North Central Cancer Treatment Group. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51. Int J Radiat Oncol Biol Phys. 2006 Aug 01; 65: (5)1429-39.
    View PubMed
  66. Jahnke K, Korfel A, O'Neill BP, Blay JY, Abrey LE, Martus P, Poortmans PM, Shenkier TN, Batchelor TT, Neuwelt EA, Raizer JJ, Schiff D, Pels H, Herrlinger U, Stein H, Thiel E. International study on low-grade primary central nervous system lymphoma. Ann Neurol. 2006 May; 59(5):755-62.
    View PubMed
  67. Vernino S, Salomao DR, Habermann TM, O'Neill BP. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology. 2005 Aug 23; 65(4):639-41.
    View PubMed
  68. Tu PH, Giannini C, Judkins AR, Schwalb JM, Burack R, O'Neill BP, Yachnis AT, Burger PC, Scheithauer BW, Perry A. Clinicopathologic and genetic profile of intracranial marginal zone lymphoma: A primary low-grade CNS lymphoma that mimics meningioma. J Clin Oncol. 2005 Aug 20; 23(24):5718-27.
    View PubMed
  69. Shenkier TN, Blay JY, O' Neill BP, Poortmans P, Thiel E, Jahnke K, Abrey LE, Neuwelt E, Tsang R, Batchelor T, Harris N, Ferreri AJM, Ponzoni M, O'Brien P, Rubenstein J, Connors JM. Primary CNS lymphoma of T-cell origin: A descriptive analysis from the International Primary CNS Lymphoma Collaborative Group. J Clin Oncol. 2005 Apr 1; 23(10):2233-9.
  70. Ghobrial IM, Buadi F, Spinner RJ, Colgan JP, Wolanskyj AP, Dyck PJ, Witzig TE, Micallef IN, O'Neill BP. High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer. 2004 Jun 1; 100 (11):2403-7
    View PubMed
  71. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG, North Central Cancer Treatment Group, Mayo Clinic. Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004 May 1; 59(1):117-25.
    View PubMed
  72. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Abrams RA, Curran WJ, Shaw EG, North Central Cancer Treatment Group//Mayo Clinic. Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58 (4):1153-60
    View PubMed
  73. Vernino S, O'Neill BP, Marks RS, O'Fallon JR, Kimmel DW. Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro Oncol. 2004 Jan; 6 (1):55-62
    View PubMed
  74. Klos KJ, O'Neill BP. Brain metastases. Neurologist. 2004 Jan; 10 (1):31-46
    View PubMed
  75. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol. 2003 Jul 1; 21 (13):2519-24
    View PubMed
  76. O'Neill BP, Iturria NJ, Link MJ, Pollock BE, Ballman KV, O'Fallon JR. A comparison of surgical resection and stereotactic radiosurgery in the treatment of solitary brain metastases. Int J Radiat Oncol Biol Phys. 2003 Apr 1; 55 (5):1169-76
    View PubMed
  77. Bartleson JD, Krecke KN, O'Neill BP, Brown PD. Reversible, strokelike migraine attacks in patients with previous radiation therapy. Neuro Oncol. 2003 Apr; 5 (2):121-7
    View PubMed
  78. Erickson BJ, Campeau NG, Schreiner SA, Buckner JC, O'Neill BP, O'Fallon JR. Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas. J Neurooncol. 2002 Oct; 60 (1):25-9
    View PubMed
  79. O'Neill BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB, Kimmel DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev. 2002 Sep; 11(9):921-4.
    View PubMed
  80. Shaw E, Arusell R, Scheithauer B, O'Fallon J, O'Neill B, Dinapoli R, Nelson D, Earle J, Jones C, Cascino T, Nichols D, Ivnik R, Hellman R, Curran W, Abrams R. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol. 2002 May 1; 20(9):2267-76.
    View PubMed
  81. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res. 2002 Jan; 8(1):180-7.
    View PubMed
  82. Schiff D, O'Neill B, Wijdicks E, Antin JH, Wen PY. Gliomas arising in organ transplant recipients: an unrecognized complication of transplantation? Neurology. 2001 Oct 23; 57(8):1486-8.
    View PubMed
  83. Meyer FB, Bates LM, Goerss SJ, Friedman JA, Windschitl WL, Duffy JR, Perkins WJ, O'Neill BP. Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc. 2001 Jul; 76(7):677-87.
    View PubMed
  84. O'Neill B, Dagam S, Iturria N, Link M, Pollock B, O'Fallon J. Comparison of microneurosurgery (MNS) and stereotactic radiosurgery (SRS) in the treatment of solitary brain metastases (SBM) Neuro-Oncology. 2001.
  85. Phan TG, O'Neill BP, Kurtin PJ. Posttransplant primary CNS lymphoma. Neuro Oncol. 2000 Oct; 2 (4):229-38
    View PubMed
  86. Fonseca R, Habermann TM, Colgan JP, O'Neill BP, White WL, Witzig TE, Egan KS, Martenson JA, Burgart LJ, Inwards DJ. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000 Jan 1; 88 (1):154-61
    View PubMed
  87. O'Neill BP, Habermann TM, Witzig TE, Rodriguez M. Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone. Med Oncol. 1999 Sep; 16 (3):211-5
    View PubMed
  88. O'Neill BP, Wang CH, O'Fallon JR, Colgan JP, Earle JD, Krigel RL, Brown LD, McGinnis WJ. The consequences of treatment and disease in patients with primary CNS non-Hodgkin's lymphoma: cognitive function and performance status. North Central Cancer Treatment Group. Neuro Oncol. 1999 Jul; 1 (3):196-203
    View PubMed
  89. Fonseca R, O'Neill BP, Foote RL, Grill JP, Sloan JA, Frytak S. Cerebral toxicity in patients treated for small cell carcinoma of the lung. Mayo Clin Proc. 1999 May; 74 (5):461-5
    View PubMed
  90. Giannini C, Scheithauer BW, Burger PC, Brat DJ, Wollan PC, Lach B, O'Neill BP. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer. 1999 May 1; 85 (9):2033-45
    View PubMed
  91. Alberts SR, Bretscher M, Wiltsie JC, O'Neill BP, Mokri B, Witzig TE. Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement. Leuk Lymphoma. 1999 Feb; 32 (5-6):489-96
    View PubMed
  92. O'Neill BP, Wang CH, O'Fallon JR, Colgan JD, Earle JD, Krigel RL, Brown LD, McGinnis WL. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): survival advantages with combined initial therapy? A final report of the North Central Cancer Treatment Group (NCCTG) Study 86-72-52. Int J Radiat Oncol Biol Phys. 1999 Feb 1; 43 (3):559-63
    View PubMed
  93. O'Neill B, Wang C, O'Fallon J, Colgan J, Earle J, Krigel R, Brown L, McGinnis W. Survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys. 1999; 43 (3):559-563.
  94. Schiff D, O'Neill BP, Wang CH, O'Fallon JR. Neuroimaging and treatment implications of patients with multiple epidural spinal metastases. Cancer. 1998 Oct 15; 83: (8)1593-601.
    View PubMed
  95. Moser HW, Moser AB, Frayer KK, Chen W, Schulman JD, Oneill BP, Kishimoto Y. Adrenoleukodystrophy - increased plasma content of saturated very long chain fatty acids. Neurology. 1998 Aug; 51(2):U 68-U 76.
    View PubMed
  96. Schiff D, Suman VJ, Yang P, Rocca WA, O'Neill BP. Risk factors for primary central nervous system lymphoma: a case-control study. Cancer. 1998 Mar 1; 82(5):975-82.
    View PubMed
  97. Burger PC, Scheithauer BW, Lee RR, O'Neill BP. An interdisciplinary approach to avoid the overtreatment of patients with central nervous system lesions. Cancer. 1997 Dec 1; 80(11):2040-6.
    View PubMed
  98. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology. 1997 Aug; 49(2):452-6.
    View PubMed
  99. Schiff D, O'Neill BP. Intramedullary spinal cord metastases: clinical features and treatment outcome. Neurology. 1996 Oct; 47 (4):906-12
    View PubMed
  100. Lyons MK, O'Neill BP, Kurtin PJ, Marsh WR. Diagnosis and management of primary spinal epidural non-Hodgkin's lymphoma. Mayo Clin Proc. 1996 May; 71 (5):453-7
    View PubMed
  101. O'Neill BP, O'Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys. 1995 Oct 15; 33(3):663-73.
    View PubMed
  102. Tomlinson FH, Kurtin PJ, Suman VJ, Scheithauer BW, O'Fallon JR, Kelly PJ, Jack CR Jr, O'Neill BP. Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg. 1995 Apr; 82 (4):558-66
    View PubMed
  103. O'Neill BP, Dinapoli RP, Kurtin PJ, Habermann TM. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough? J Neurooncol. 1995; 25 (1):67-71
    View PubMed
  104. O'Neill BP, Buckner JC, Coffey RJ, Dinapoli RP, Shaw EG. Brain metastatic lesions. Mayo Clin Proc. 1994 Nov; 69 (11):1062-8
    View PubMed
  105. Kaufman DK, Habermann TM, Kurtin PJ, O'Neill BP. Neurological complications of peripheral and cutaneous T-cell lymphomas. Ann Neurol. 1994 Oct; 36 (4):625-9
    View PubMed
  106. Cheng TM, O'Neill BP, Scheithauer BW, Piepgras DG. Chronic meningitis: the role of meningeal or cortical biopsy. Neurosurgery. 1994 Apr; 34 (4):590-5; discussion 596
    View PubMed
  107. Robb RA, Camp JJ, Bourland JD, Jack CR, O'Neill BP. Tumor volume analysis using 3-D image registration and segmentation by feature analysis. Special & Life Sciences Engineering. 1994; Edition:Medical.
  108. Deangelis LM, O'Neill BP. Diagnostic and therapeutic challenges of primary CNS lymphoma. (Seminar no. 416). Neurology. 1993 Apr; 43(Suppl):A127.
  109. Meneses MS, O'Neill BP, Kelly PJ. [Stereotaxic biopsy for primary lymphomas of the central nervous system]. Arq Neuropsiquiatr. 1992 Sep; 50 (3):319-23
    View PubMed
  110. Lyons MK, O'Neill BP, Marsh WR, Kurtin PJ. Primary spinal epidural non-Hodgkin's lymphoma: report of eight patients and review of the literature. Neurosurgery. 1992 May; 30 (5):675-80
    View PubMed
  111. Herkes GK, Partington MD, O'Neill BP. Neurological features of cranial vault lymphomas: report of two cases. Neurosurgery. 1991 Dec; 29 (6):898-901
    View PubMed
  112. Inwards DJ, Piepgras DG, Lie JT, O'Neill BP, Scheithauer BW, Habermann TM. Granulomatous angiitis of the spinal cord associated with Hodgkin's disease. Cancer. 1991 Sep 15; 68 (6):1318-22
    View PubMed
  113. Lachance DH, O'Neill BP, Macdonald DR, Jaeckle KA, Witzig TE, Li CY, Posner JB. Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature. Neurology. 1991 Jan; 41 (1):95-100
    View PubMed
  114. Lachance DH, O'Neill BP, Harper CM Jr, Banks PM, Cascino TL. Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease. Mayo Clin Proc. 1991 Jan; 66 (1):97-101
    View PubMed
  115. Hetzel DJ, Stanhope CR, O'Neill BP, Lennon VA. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin Proc. 1990 Dec; 65 (12):1558-63
    View PubMed
  116. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc. 1990 Nov; 65 (11):1423-31
    View PubMed
  117. O'Neill BP, Habermann TM, Banks PM, O'Fallon JR, Earle JD. Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia. Cancer. 1989 Sep 15; 64 (6):1296-300
    View PubMed
  118. O'Neill BP, Illig JJ. Primary central nervous system lymphoma. Mayo Clin Proc. 1989 Aug; 64 (8):1005-20
    View PubMed
  119. Hartmann LC, Oliver GF, Winkelmann RK, Colby TV, Sundt TM Jr, O'Neill BP. Blue nevus and nevus of Ota associated with dural melanoma. Cancer. 1989 Jul 1; 64 (1):182-6
    View PubMed
  120. Frytak S, Shaw JN, O'Neill BP, Lee RE, Eagan RT, Shaw EG, Richardson RL, Coles DT, Jett JR. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol. 1989 Feb; 12 (1):27-33
    View PubMed
  121. Rodriguez M, Truh LI, Rodriguez M, O'Neill BP, Lennon VA. Autoimmune paraneoplastic cerebellar degeneration: ultrastructural localization of antibody-binding sites in Purkinje cells. Neurology. 1988 Sep; 38 (9):1380-6
    View PubMed
  122. Jack CR Jr, O'Neill BP, Banks PM, Reese DF. Central nervous system lymphoma: histologic types and CT appearance. Radiology. 1988 Apr; 167 (1):211-5
    View PubMed
  123. Kimmel DW, O'Neill BP, Lennon VA. Subacute sensory neuronopathy associated with small cell lung carcinoma: diagnosis aided by autoimmune serology. Mayo Clin Proc. 1988 Jan; 63 (1):29-32
    View PubMed
  124. O'Neill BP, Dinapoli RP, Okazaki H. Cerebral infarction as a result of tumor emboli. Cancer. 1987 Jul 1; 60(1):90-5.
    View PubMed
  125. O'Neill BP, Kelly PJ, Earle JD, Scheithauer B, Banks PM. Computer-assisted stereotaxic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology. 1987 Jul; 37(7):1160-4.
    View PubMed
  126. So NK, O'Neill BP, Frytak S, Eagan RT, Earnest F 4th, Lee RE. Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology. 1987 Jul; 37(7):1198-201.
    View PubMed
  127. O'Neill BP, Banks PM, O'Fallon JR, Earle JD, Colgan JP. Primary central nervous system non-Hodgkin's lymphoma (pcnsi): a clinical, radiological and pathological study of 51 patients in the ct-era (1974-1986). Proc Annu Meet Am Soc Clin Oncol. 1987 Mar; 6:70.
  128. Eagan RT, Dinapoli RP, Cascino TL, Scheithauer B, O'Neill BP, O'Fallon JR. Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors. J Neurooncol. 1987; 5 (4):309-14
    View PubMed
  129. Matsumoto JY, O'Neill BP, Piepgras DG, Scheithauer B. Metastatic malignant glioma with resultant extradural compression of a sacral nerve root. J Neurooncol. 1987; 4(3):227-31.
    View PubMed
  130. Hagen NA, O'Neill BP, Kelly PJ. Computer assisted stereotactic placement of Ommaya reservoirs for delivery of chemotherapeutic agents in cancer patients. J Neurooncol. 1987; 5 (3):273-6
    View PubMed
  131. Frytak S, Earnest F 4th, O'Neill BP, Lee RE, Creagan ET, Trautmann JC. Magnetic resonance imaging for neurotoxicity in long-term survivors of carcinoma. Mayo Clin Proc. 1985 Dec; 60(12):803-12.
    View PubMed
  132. O'Neill BP, Swanson JW, Brown FR 3rd, Griffin JW, Moser HW. Familial spastic paraparesis: an adrenoleukodystrophy phenotype? Neurology. 1985 Aug; 35(8):1233-5.
    View PubMed
  133. Hill LM, Parker D, O'Neill BP. Management of maternal vegetative state during pregnancy. Mayo Clin Proc. 1985 Jul; 60:469-472.
    View PubMed
  134. Harper CM Jr, O'Neill BP, O'Duffy JD, Forbes GS. Intracranial hypertension in Behcet's disease: demonstration of sinus occlusion with use of digital subtraction angiography. Mayo Clin Proc. 1985 Jun; 60:419-422.
    View PubMed
  135. O'Neill BP, Kelly PJ, Kall BA, Goerss SJ, Earnest F, Cascino TL, Dinapoli RP. Computer assisted stereotactic laser resection of intra-axial tumors. Neurology. 1985; 35(4):289-90.
  136. Kimmel DW, Hermann RC Jr, O'Neill BP. Neurologic complications of hairy cell leukemia. Arch Neurol. 1984 Feb; 41(2):202-3.
    View PubMed
  137. Marler JR, O'Neill BP, Forbes GS, Moser HW. Adrenoleukodystrophy (ALD): clinical and CT features of a childhood variant. Neurology. 1983 Sep; 33(9):1203-5.
    View PubMed
  138. Tuck RR, O'Neill BP, Gharib H, Mulder DW. Familial spastic paraplegia with Kallmann's syndrome. Journal of Neurology, Neurosurgery & Psychiatry. 1983 Jul; 46(7):671-4.
    View PubMed
  139. Kimmel DW, O'Neill BP. Systemic cancer presenting as diabetes insipidus. Clinical and radiological features of 11 patients with a review of metastatic-induced diabetes insipidus. Cancer. 1983; 542:2355-8.
  140. O'Neill BP, Aronson AE, Pearson BW, Nauss LA. Superior laryngeal neuralgia: carotidynia or just another pain in the neck? Headache. 1982 Jan; 22 (1):6-9
    View PubMed
  141. Ahlskog JE, O'Neill BP. Pseudotumor Cerebri. Annals of Internal Medicine. 1982; 97:249-56.
    View PubMed
  142. O'Neill BP, Forbes GS. Computerized tomography and adrenoleukomyeloneuropathy: differential appearance in disease subtypes. Arch Neurol. 1981 May; 38:293-296.
    View PubMed
  143. O'Neill BP, Marmion LC, Feringa ER. The adrenoleukomyeloneuropathy complex: expression in four generations. Neurology. 1981 Feb; 31:151-156.
    View PubMed
  144. Kroll P, Seigel R, O'Neill BP. Cerebral cortical atrophy in alcoholic men. J Clin Psychiatry. 1980 Dec; 41:417-421.
    View PubMed
  145. Weiss GM, Nelson RL, O'Neill BP, Carney JA, Edis AJ. Use of adrenal biopsy in diagnosing adrenoleukomyeloneuropathy. Arch Neurol. 1980 Oct; 37(10):634-6.
    View PubMed
  146. O'Neill BP, Kapur JJ, Good AE. HLA antigens in migraine. Headache. 1979 Mar; 19(2):71-3.
    View PubMed
  147. O'Neill BP, Butler AB, Young E, Falk PM, Bass NH. Adult onset GM2 gangliosidosis: seizures, dementia and normal pressure hydrocephalus associated with glycolipid storage in brain and arachnoid granulation. Neurology. 1978; 28:1117-1123.
    View PubMed
  148. O'Neill BP, Mann JD. Aspirin prophylaxis in migraine. Lancet. 1978; 2:1179-1181.
    View PubMed
  149. O'Neill BP, Ladon B, Harris L, Riley HL, Dreifuss FE. Evaluation of a comprehensive, interdisciplinary approach to the care of the institutionalized epileptic. Epilepsia. 1977; 18:243-250.
    View PubMed
  150. O'Neill BP. Passive ocular proptosis. J Neurol Neurosurg Psychiatry. 1977; 40:1198-1202.
    View PubMed
  151. O'Neill BP. HEW report: approaches to improved care of institutionalized epileptic persons. The University of Virginia School of Medicine Effort Developmental Disabilities Training and Technical Assistance Center M Rose, Ed Univ. 1977; 5-7.
  152. Logan WJ, O'Neill BP. Amino acid neural transport systems in normal and experimental conditions. Trans Am Neurol Assoc. 1976; 101:1-2.
    View PubMed
  153. Strong AJ, Symon L, Macgregor BJL, O'Neill BP. Coincidental meningioma and glioma. J Neurosurg. 1976; 45:455-458.
    View PubMed